Newsfeeds - Spark Newswire

1 minute read

Maxim Group Initiates Coverage On Clarus Therapeutics Hldgs with Buy Rating, Announces Price Target of $13

Today, 6:31 PM

Maxim Group analyst Naz Rahman initiates coverage on Clarus Therapeutics Hldgs (NASDAQ:CRXT) with a Buy rating and announces Price Target of $13.

CRXT

5 minute read

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer’s Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive

By Shanthi Rexaline

Today, 6:31 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27)

AFIB

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 6:31 PM

Gainers

ACY

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 20, 2021

By Benzinga Insights

Today, 6:31 PM

ACHC

1 minute read

Oppenheimer Initiates Coverage On Clarus Therapeutics Hldgs with Outperform Rating, Announces Price Target of $12

By Benzinga Newsdesk

Today, 6:31 PM

Oppenheimer analyst Leland Gershell initiates coverage on Clarus Therapeutics Hldgs (NASDAQ:CRXT) with a Outperform rating and announces Price Target of $12.

CRXT

1 minute read

Cantor Fitzgerald Initiates Coverage On Clarus Therapeutics Hldgs with Overweight Rating, Announces Price Target of $20

By Benzinga Newsdesk

Today, 6:31 PM

Cantor Fitzgerald analyst Louise Chen initiates coverage on Clarus Therapeutics Hldgs (NASDAQ:CRXT) with a Overweight rating and announces Price Target of $20.

CRXT

1 minute read

Clarus Therapeutics, McGill University Ink Licensing Pact For Rare CoQ10-Associated Conditions

By Vandana Singh

Today, 6:31 PM

Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) and Canada’s McGill University have announced licensing agreement whereby Clarus will develop and commercialize McGill’s proprietary…

CRXT

5 minute read

60 Biggest Movers From Friday

By Lisa Levin

Today, 6:31 PM

Gainers

ABUS

4 minute read

41 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 6:31 PM

Gainers

ABUS